{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:26:09Z","timestamp":1780590369637,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02361697"],"award-info":[{"award-number":["RF-2016-02361697"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jad.2025.120724","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:01:09Z","timestamp":1763636469000},"page":"120724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PA","title":["Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch"],"prefix":"10.1016","volume":"395","author":[{"given":"Alessandro","family":"Serretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Barlati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Buson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Menesello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Magistrali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana Carvalho","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Perusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Nibbio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bignotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Tura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gennarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Minelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7748","key":"10.1016\/j.jad.2025.120724_bb0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","article-title":"Scientists rise up against statistical significance","volume":"567","author":"Amrhein","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jad.2025.120724_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cpt.2903","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants","volume":"114","author":"Bousman","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jad.2025.120724_bb0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12888-024-05764-6","article-title":"Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study","volume":"24","author":"Brouwer","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2025.120724_bb0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2217\/pgs-2019-0157","article-title":"The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis","volume":"21","author":"Brown","year":"2020","journal-title":"Pharmacogenomics"},{"issue":"115102","key":"10.1016\/j.jad.2025.120724_bb0025","article-title":"Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: a rapid review and meta-analysis","volume":"321","author":"Bunka","year":"2023","journal-title":"Psychiatry Res."},{"issue":"14","key":"10.1016\/j.jad.2025.120724_bb0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/pgs-2022-0087","article-title":"The importance of phenoconversion when using the CYP2D6 genotype in clinical practice","volume":"23","author":"Cicali","year":"2022","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jad.2025.120724_bb0035","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"2","key":"10.1016\/j.jad.2025.120724_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/YIC.0000000000000520","article-title":"Relevance of pharmacogenetic analyses and therapeutic drug monitoring of antidepressants for an individualized treatment of peripartum psychopathology","volume":"39","author":"Colombo","year":"2024","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120724_bb0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.psychres.2016.04.034","article-title":"Socio-demographic and clinical predictors of non-response\/non-remission in treatment resistant depressed patients: a systematic review","volume":"240","author":"De Carlo","year":"2016","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.jad.2025.120724_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/pharmaceutics13020148","article-title":"Assessing the mechanism of fluoxetine-mediated CYP2D6 inhibition","volume":"13","author":"Deodhar","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.jad.2025.120724_bb0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.euroneuro.2018.05.009","article-title":"Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studies","volume":"28","author":"Fabbri","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2025.120724_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"44","key":"10.1016\/j.jad.2025.120724_bb0065","first-page":"E1499","article-title":"Cost-effectiveness of pharmacogenomic-guided treatment for major depression","volume":"195","author":"Ghanbarian","year":"2023","journal-title":"Journal de l\u2019Association Medicale Canadienne [Canadian Medical Association Journal]"},{"key":"10.1016\/j.jad.2025.120724_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpsychires.2019.01.003","article-title":"Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: a large, patient- and rater-blinded, randomized, controlled study","volume":"111","author":"Greden","year":"2019","journal-title":"J. Psychiatr. Res."},{"issue":"1\u221202","key":"10.1016\/j.jad.2025.120724_bb0075","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120724_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-02124-4","article-title":"Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study","volume":"12","author":"Islam","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.120724_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.740216","article-title":"What are the barriers and enablers to the implementation of pharmacogenetic testing in mental health care settings?","volume":"12","author":"Jameson","year":"2021","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.jad.2025.120724_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/FPC.0000000000000406","article-title":"Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients","volume":"30","author":"Jessel","year":"2020","journal-title":"Pharmacogenet. Genomics"},{"issue":"114535","key":"10.1016\/j.jad.2025.120724_bb0095","article-title":"CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability","volume":"312","author":"Jokovi\u0107","year":"2022","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.jad.2025.120724_bb0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1176\/appi.ajp.2017.17050550","article-title":"Impact of CYP2C19 genotype on escitalopram exposure and therapeutic failure: a retrospective study based on 2,087 patients","volume":"175","author":"Juki\u0107","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2025.120724_bb0105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.mp.4001494","article-title":"Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response","volume":"9","author":"Kirchheiner","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.120724_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"3","key":"10.1016\/j.jad.2025.120724_bb0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jamapsychiatry.2020.3643","article-title":"Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure: a systematic review and meta-analysis","volume":"78","author":"Milosavljevic","year":"2021","journal-title":"JAMA Psychiatry (Chicago, Ill.)"},{"issue":"1","key":"10.1016\/j.jad.2025.120724_bb0120","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1186\/s13063-021-05775-8","article-title":"Clinical validation of a combinatorial PharmAcogeNomic approach in major depressive disorder: an observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)","volume":"22","author":"Minelli","year":"2021","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.jad.2025.120724_bb0125","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cpt.1135","article-title":"CYP2D6 genotype phenotype discordance due to drug-drug interaction","volume":"104","author":"Monte","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.jad.2025.120724_bb0130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17425255.2022.2160317","article-title":"CYP2D6 pharmacogenetics and phenoconversion in personalized medicine","volume":"18","author":"Nahid","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.jad.2025.120724_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2022.9805","article-title":"Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder: the PRIME care randomized clinical trial","volume":"328","author":"Oslin","year":"2022","journal-title":"JAMA: the JAMA"},{"issue":"5","key":"10.1016\/j.jad.2025.120724_bb0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15622975.2022.2134588","article-title":"Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting","volume":"24","author":"Panariello","year":"2023","journal-title":"The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120724_bb0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41431-019-0480-8","article-title":"Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe","volume":"28","author":"Petrovi\u0107","year":"2020","journal-title":"European Journal of Human Genetics: EJHG"},{"issue":"11","key":"10.1016\/j.jad.2025.120724_bb0150","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2025.120724_bb0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/YIC.0000000000000562","article-title":"Mood disorders and somatic comorbidities","volume":"39","author":"Serretti","year":"2024","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2025.120724_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725021664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725021664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:32:11Z","timestamp":1766104331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725021664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S0165032725021664"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120724","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120724"}}